608137-33-3
11 Inquiries
608137-33-3
kg
2023-01-08
Custom Synthetic Chemicals,Biological Stains,Pharmaceutical Intermediates,Cosmetic Grade Chemicals,Enzyme,Nucleosides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceVyvanse is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|Lisdexamfetamine Dimesylate is the dimesylate form and prodrug of the d-isomer of amphetamine, a non-catecholamine sympathomimetic amine with central nervous system (CNS) stimulating activity. Upon administration, lisdexamphetamine is converted to dextroamphetamine through cleavage of the lysine group. Dextroamphetamine acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from its storage sites in nerve terminals in the CNS, and inhibits their uptake within the mesocorticolimbic system, a major component of the brain reward system, resulting in measurable behavioral changes such as euphoria, mental alertness and excitement and appetite suppression. As a CNS stimulant, this agent may increase blood pressure.|A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.Basic Info
-
Product Name:
Lisdexamfetamine dimesylate
Other Name:Hexanamide,2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-,(2S)-,methanesulfonate (1:2);Hexanamide,2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-,(2S)-,dimethanesulfonate;NRP 104;Lisdexamfetamine dimesylate;Vyvanse;SPD 489;N-(L-Lysyl)-D-amphetamine dimesylate;Lisdexamphetamine dimesylate
CAS No.:608137-33-3
Molecular Formula:C15H25N3O.2CH4O3S
InChIKeys:InChIKey=KZHOHVKYLXWNQP-KYSPHBLOSA-N
Molecular Weight:455.58982
Exact Mass:455.17600
EC Number:200-659-6
UNII:SJT761GEGS
DEA Code Number:1205
DSSTox ID:DTXSID60209653
NCI Thesaurus Code:C76628
Categories:
Characteristics-
PSA:
207
XLogP3:4.15120
Boiling Point:488ºC at 760 mmHg
Flash Point:9℃
Storage Conditions:-20°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Custom Synthetic Chemicals,Biological Stains,Pharmaceutical Intermediates,Cosmetic Grade Chemicals,Enzyme,Nucleosides
-
Location:
Room 308-80, building 1, 1963 Huaguan Road, Tianhe District, Guangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,100% TT in advance
-
Average lead Time:
30
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
-
Inquiry History11 Inquiries
Country Product Purchase Quantity Date Posted
Canada
99% Purity CAS 608137-33-3 Raw Powder Door to Door Service
10 G Oct 23, 2023
Canada
608137-33-3
1 KG Jun 21, 2026
United States
608137-33-3
1 G Sep 13, 2025
Germany
608137-33-3
10 MT Oct 27, 2023
Bangladesh
99% Purity CAS 608137-33-3 Raw Powder Door to Door Service
8 MT Nov 8, 2023
India
Lisdexamfetamine Dimesylate
2 G Aug 11, 2025
United Arab Emirates
lisdexamfétamine dimesylate
10 G Aug 6, 2026
United States
Vyvance
5 G May 2, 2026
Canada
Vyvanse
1 MT Jan 31, 2026
Canada
Vyvanse
10 G Nov 6, 2025
United Kingdom
lisdexamfetamine dimesylate
1 KG Mar 19, 2024 Post an enquiry for this product